AZN.UK

10,640

+2.17%↑

GSK

1,510

+3.64%↑

INDV

939

+4.22%↑

AZN.UK

10,640

+2.17%↑

GSK

1,510

+3.64%↑

INDV

939

+4.22%↑

AZN.UK

10,640

+2.17%↑

GSK

1,510

+3.64%↑

INDV

939

+4.22%↑

AZN.UK

10,640

+2.17%↑

GSK

1,510

+3.64%↑

INDV

939

+4.22%↑

AZN.UK

10,640

+2.17%↑

GSK

1,510

+3.64%↑

INDV

939

+4.22%↑

Search

Oxford Biomedica PLC

Fechado

318.5

Visão Geral

Variação de preço das ações

24h

Atual

Mín

317

Máximo

321.5

Indicadores-chave

By Trading Economics

Rendimento

22M

-11M

Vendas

27M

78M

Margem de lucro

-13.726

Funcionários

850

EBITDA

25M

5M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+99.99% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

31M

339M

Abertura anterior

318.5

Fecho anterior

318.5

Oxford Biomedica PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

30 de mai. de 2025, 23:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 de mai. de 2025, 21:30 UTC

Principais Notícias

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 de mai. de 2025, 21:15 UTC

Principais Notícias

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 de mai. de 2025, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

30 de mai. de 2025, 20:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 de mai. de 2025, 20:24 UTC

Principais Notícias

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 de mai. de 2025, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

30 de mai. de 2025, 19:44 UTC

Conversa de Mercado

Gold Breaks 4-Month Winning Streak -- Market Talk

30 de mai. de 2025, 19:38 UTC

Conversa de Mercado

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 de mai. de 2025, 19:29 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 de mai. de 2025, 19:14 UTC

Conversa de Mercado

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 de mai. de 2025, 19:05 UTC

Conversa de Mercado

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 de mai. de 2025, 18:51 UTC

Conversa de Mercado

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 de mai. de 2025, 18:37 UTC

Conversa de Mercado
Ganhos

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 de mai. de 2025, 18:04 UTC

Principais Notícias

S&P 500 Falls After More Trump-China Friction -- WSJ

30 de mai. de 2025, 17:47 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 de mai. de 2025, 17:47 UTC

Conversa de Mercado

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 de mai. de 2025, 17:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 de mai. de 2025, 17:38 UTC

Conversa de Mercado

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 de mai. de 2025, 17:31 UTC

Conversa de Mercado

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 de mai. de 2025, 17:14 UTC

Principais Notícias

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30 de mai. de 2025, 16:31 UTC

Ganhos

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30 de mai. de 2025, 16:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

30 de mai. de 2025, 16:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

30 de mai. de 2025, 16:16 UTC

Principais Notícias

S&P 500 Falls After Trump Hits Out at China -- WSJ

30 de mai. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

30 de mai. de 2025, 16:14 UTC

Principais Notícias

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

30 de mai. de 2025, 16:12 UTC

Conversa de Mercado

Base Metal Prices Slide on Stronger Dollar But Copper Shortage Fears Remain -- Market Talk

30 de mai. de 2025, 16:02 UTC

Conversa de Mercado

Latest Twists in U.S. Tariff Saga Being Digested by Commodity Markets -- Market Talk

30 de mai. de 2025, 15:31 UTC

Principais Notícias

Judge Considers Curbs for Google in AI Arms Race -- Update

Comparação entre Pares

Variação de preço

Oxford Biomedica PLC Previsão

Preço-alvo

By TipRanks

99.99% parte superior

Previsão para 12 meses

Média 649.978 GBX  99.99%

Máximo 800 GBX

Mínimo 500 GBX

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Oxford Biomedica PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

2

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.